Lucentis vs. Avastin
What is Lucentis?
Lucentis, also known as Ranibizumab, is a drug used to treat sufferers of wet-aged macular degeneration. Lucentis was approved by the U.S. Food and Drug Administration in 2006 and has been in use since then. Only available on prescription, Lucentis is injected into the eye by a retina specialist.
As with all drugs, Lucentis has some side effects, with which patients should be familiar. Chief among the side effects are eye pain, increased eye pressure, headaches and nausea. Though rare, more serious side effects include, intraocular inflammation and blindness.
What is Avastin?
Avastin, medical name Bevacizumab, is also used to slow wet-aged macular degeneration. Injected into the eye, Avastin inhibits the growth of new blood vessels. Receiving FDA approval in 2004, Avastin was originally designed to slow the growth of metastic colon cancer, along side chemotherapy. It has since been used off-label by ophthalmologists, to treat various eye diseases, including wAMD.
Side effects of Avastin can include, increased risk of bleeding and high blood pressure. However, these effects are generally lessened when Avastin is injected into the eye.